Equitable Trust’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,577
Closed -$328K 462
2025
Q1
$328K Hold
2,577
0.02% 390
2024
Q4
$371K Hold
2,577
0.02% 379
2024
Q3
$384K Buy
2,577
+891
+53% +$128K 0.02% 359
2024
Q2
$213K Buy
+1,686
New +$264K 0.01% 421

Other funds holding RGEN

Equitable Trust's RGEN Position: Q2 2025 in Review

Equitable Trust sold out of Repligen (RGEN) in Q2 2025, closing a stake of 2,577 shares — an estimated $328K sold.

Equitable Trust first reported a position in RGEN in Q2 2024 and held it in 4 quarters. The position peaked at $384K in Q3 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Equitable Trust reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Equitable Trust sold 2,577 Repligen shares in Q2 2025, an estimated $328K.
  • Equitable Trust first reported a position in Repligen in Q2 2024 and held it in 4 quarters.
  • Equitable Trust's Repligen position peaked at $384K in Q3 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Equitable Trust's 13F filing for Q2 2025, filed 23 Jul 2025.